Range
14.28 - 15.08
Vol / Avg.
28.3K/84.2K
Div / Yield
-
52 Wk
10.4 - 24.84
Mkt Cap
162.9M
Payout Ratio
-
Open
14.91
P/E
-
EPS
-0.55
Shares
11.2M
Outstanding
11.2M
Total Float
8.1M
Benzinga - May 25, 2021, 8:14AM
Benzinga - May 12, 2021, 11:45AM
Benzinga - May 3, 2021, 4:49PM
Benzinga - May 3, 2021, 7:43AM
Benzinga - May 3, 2021, 7:19AM
Benzinga - Apr 29, 2021, 7:27AM
Benzinga - Apr 26, 2021, 7:47AM
Benzinga - Apr 1, 2021, 8:00AM
Benzinga - Mar 23, 2021, 7:50AM
Benzinga - Mar 17, 2021, 7:09AM
Benzinga - Mar 10, 2021, 4:01PM
Benzinga - Jan 15, 2021, 5:49AM
Benzinga - Jan 6, 2021, 3:48PM
Benzinga - Jan 6, 2021, 9:20AM
Benzinga - Jan 4, 2021, 7:03AM
Benzinga - Dec 17, 2020, 7:05AM
Benzinga - Dec 15, 2020, 7:04AM
Benzinga - Dec 8, 2020, 8:32AM
Benzinga - Oct 29, 2020, 4:00PM
Benzinga - Oct 12, 2020, 10:30AM
Benzinga - Oct 5, 2020, 7:47AM
load more
Sector: Health Care.Industry: Biotechnology
Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves three small molecule drug candidates namely LP-100, LP-184, and LP-300.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-29
REV
Q1 2021Est.ActualSurprise
EPS-0.270-0.240 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
LTRNLantern Pharma-1.89%162.9M

Lantern Pharma Frequently Asked Questions

Q

How do I buy Lantern Pharma (LTRN) stock?

A

You can purchase shares of Lantern Pharma (NASDAQ: LTRN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lantern Pharma's (LTRN) competitors?

A

Other companies in Lantern Pharma’s space includes: Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), Heat Biologics (NASDAQ:HTBX), Voyager Therapeutics (NASDAQ:VYGR) and T2 Biosystems (NASDAQ:TTOO).

Q

What is the target price for Lantern Pharma (LTRN) stock?

A

The latest price target for Lantern Pharma (NASDAQ: LTRN) was reported by Colliers Securities on July 28, 2020. The analyst firm set a price target for 24.00 expecting LTRN to rise to within 12 months (a possible 64.72% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lantern Pharma (LTRN)?

A

The stock price for Lantern Pharma (NASDAQ: LTRN) is $14.57 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Lantern Pharma (LTRN) pay a dividend?

A

There are no upcoming dividends for Lantern Pharma.

Q

When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?

A
Lantern Pharma’s Q2 earnings are confirmed for after-market on July 29, 2021.
Q

Is Lantern Pharma (LTRN) going to split?

A

There is no upcoming split for Lantern Pharma.

Q

What sector and industry does Lantern Pharma (LTRN) operate in?

A

Lantern Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.